NCT01063517 - Efficacy Study of Olaparib With Paclitaxel Versus Paclitaxel in Gastric Cancer Patients | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

February 2, 2010

Primary Completion Date

May 11, 2012

Study Completion Date

June 29, 2023

Conditions

Gastric Cancer

Interventions

DRUG

olaparib

100mg BID oral tablet continuous

DRUG

paclitaxel

iv infusion 80mg/m2 on Day 1, 8 and 15 of a 28 day cycle

DRUG

Placebo

100mg BID oral tablet to match olaparib tablet

Trial Locations (7)

Research Site, Goyang-si

Research Site, Jeonnam

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Seoul

Research Site, Taegu